Leishmania pp 237-247 | Cite as

Generation of Bone Marrow-Derived Macrophages for In Vitro Infection Experiments

  • Eugenia Bifeld
Part of the Methods in Molecular Biology book series (MIMB, volume 1971)


Murine bone marrow-derived macrophages (BMMs) can be differentiated within 10 days from ex vivo bone marrow progenitor cells by supplementing the cell growth medium with colony stimulating factor-1 (CSF-1). Mature macrophages express specific myeloid markers which can be labeled and detected by flow cytometry (FACS).

BMMs are a valuable tool to investigate the interactions between the Leishmania parasites and their host cell as well as to screen anti-Leishmania components. Options for the readout of in vitro infection experiments are diverse and may range from simple counting of intracellular parasites to the determination of metabolic changes of the intracellular parasite or the infected cell, thus providing the investigator with valuable results.

Key words

Bone marrow-derived macrophages Colony stimulating factor-1 Flow cytometry 



Thanks to Andrea MacDonald and Christine Brinker for help with handling the cell cultures, and to Dr. Hannah Bernin and Dr. Julie Sellau for advice regarding the FACS analysis.


  1. 1.
    Stanley ER, Guilbert LJ (1981) Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1). J Immunol Methods 42(3):253–284CrossRefGoogle Scholar
  2. 2.
    Clark SC, Kamen R (1987) The human hematopoietic colony-stimulating factors. Science 236(4806):1229–1237CrossRefGoogle Scholar
  3. 3.
    Eske K, Breitbach K, Kohler J, Wongprompitak P, Steinmetz I (2009) Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J Immunol Methods 342(1–2):13–19. Scholar
  4. 4.
    Hume DA, Gordon S (1982) Regulation of bone-marrow macrophage proliferation. Adv Exp Med Biol 155:261–266CrossRefGoogle Scholar
  5. 5.
    Sherr CJ, Rettenmier CW, Roussel MF (1988) Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor. Cold Spring Harb Symp Quant Biol 53(Pt 1):521–530CrossRefGoogle Scholar
  6. 6.
    Englen MD, Valdez YE, Lehnert NM, Lehnert BE (1995) Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. J Immunol Methods 184(2):281–283CrossRefGoogle Scholar
  7. 7.
    Tushinski RJ, Oliver IT, Guilbert LJ, Tynan PW, Warner JR, Stanley ER (1982) Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28(1):71–81CrossRefGoogle Scholar
  8. 8.
    Sklar MD, Tereba A, Chen BD, Walker WS (1985) Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1. J Cell Physiol 125(3):403–412. Scholar
  9. 9.
    Sieff CA, Niemeyer CM, Mentzer SJ, Faller DV (1988) Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells. Blood 72(4):1316–1323PubMedGoogle Scholar
  10. 10.
    Olivas E, Chen BB, Walker WS (1995) Use of the Pannell-Milstein roller bottle apparatus to produce high concentrations of the CSF-1, the mouse macrophage growth factor. J Immunol Methods 182(1):73–79CrossRefGoogle Scholar
  11. 11.
    Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W (1994) Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174(1–2):5–19CrossRefGoogle Scholar
  12. 12.
    Tabel H, Kaushik RS, Uzonna J (1999) Experimental African trypanosomiasis: differences in cytokine and nitric oxide production by macrophages from resistant and susceptible mice. Pathobiology 67(5–6):273–276. Scholar
  13. 13.
    Kaushik RS, Uzonna JE, Zhang Y, Gordon JR, Tabel H (2000) Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice. Cytokine 12(7):1024–1034. Scholar
  14. 14.
    Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2(11):845–858. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Eugenia Bifeld
    • 1
    • 2
  1. 1.Bernhard Nocht Institute for Tropical MedicineHamburgGermany
  2. 2.altona Diagnostics GmbHHamburgGermany

Personalised recommendations